About this trial
Glaucoma medications are vital to disease management and prevention of further loss of vision as over time glaucoma will lead to irreversible blindness. The average size of a glaucoma medication bottle is around 10cc and these medications when used 2-3 times daily are expected to last patients an entire month. The investigators found that at Boston Medical Center (BMC) a majority of Yawkey Eye Clinic patients are unable to deliver the drops into their eyes due to poor vision or difficulty squeezing drop bottles. These patients also often deliver more than a necessary amount leading to premature completion of the bottle. However, because the cost benefit ratio of these drop aids is unclear, they are not routinely offered to the patients. Although the efficacy of these drop aids has not been well studied, if effective, the cost of these drop aids would more than pay themselves by improving medication compliance and visual function of the patients. This study aims to determine the efficacy of the Nanodropper in the BMC Yawkey Eye Clinic patient population.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Currently on the same topical ophthalmic medications for treatment of glaucoma for a minimum of two months
Patient of Boston University Eye Associates
Disqualifiers
Changed glaucoma medications within the past 2 months
Trial design
Crossover
Treatments tested in this trial
Nanodropper
DeviceThe Nanodropper is the only FDA-listed, volume-reducing adaptor for eyedrop bottles. By twisting the Nanodropper onto a compatible bottle, the drop-size can be reduced by over 60%. Smaller drops have been shown to reduce waste, cost, and side effects.
Treatment groups
Trial outcomes
Primary outcomes
Completion of topical ophthalmic drug bottle
This outcome will be measured in days by the patient from when a bottle is started until all the medication has been used.
Satisfaction with dispensing opthalmic medication
An investigator developed survey completed by participants will be used to assess participants' satisfaction of eye drops with and without the drop aid.
Secondary outcomes
Change in intraocular pressure with drop aid
An applanator will be used to measure the intraocular pressure during standard of care appointments.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Boston Medical Center
Lead sponsor
Boston Medical Center Patient Safety Grant
Collaborator
This trial is not recruiting at the moment. You can still explore other options: